Advertisement

Epi-embryonic stem cells?

Researchers have provided clues about a potentially new source of human stem cells that are physically close to the actual embryo, but miles away from the controversy surrounding its use in research. Last night, at the linkurl:Keystone meeting;http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=786 on stem cells, linkurl:Ursula Manuelpillai;http://www.med.monash.edu.au/ob-gyn/staff/ursulam.html at the Monash Institute of Medical Research in Victoria, Australia presented a poster

By | April 1, 2006

Researchers have provided clues about a potentially new source of human stem cells that are physically close to the actual embryo, but miles away from the controversy surrounding its use in research. Last night, at the linkurl:Keystone meeting;http://www.keystonesymposia.org/Meetings/ViewMeetings.cfm?MeetingID=786 on stem cells, linkurl:Ursula Manuelpillai;http://www.med.monash.edu.au/ob-gyn/staff/ursulam.html at the Monash Institute of Medical Research in Victoria, Australia presented a poster in which they detail the potential of human amniotic epithelial cells (HAECs) in the inner membrane that protects the fetus during pregnancy. The researchers exposed HAECs to factors that nudge them to differentiate into cell types. Indeed, the cells displayed markers that suggest they differentiated into a variety of cells, such as astrocytes, neurons, hepatocytes, and pancreatic cells. "I?m not saying the cells are pluripotent, but they certainly have the markers of pluripotency," Manuelpillai told me. HAECs did not produce teratomas in mice testes -- an initially disappointing result, Manuelpillai said, since teratomas are characteristic of pluripotent cells. But upon further consideration, Manuelpillai noted that this inability might make them more useful for therapy down the road. In contrast to cells from umbilical cords, HAECs are easier to isolate and also divide more easily, and one membrane can yield 60 million cells -- significantly more than what one gets from umbilical cords, Manuelpillai said. She added that she and her colleagues have submitted the paper for publication, and plan to continue injecting the cells into diseased mice to test their therapeutic potential.
Advertisement
Keystone Symposia
Keystone Symposia

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
UVP
UVP
Advertisement
NeuroScientistNews
NeuroScientistNews